InsidersTradesSigma
迪哲医药: directors' dealings · France · AMF
SSE:688192FR·AMFMcap 26.6Bn€
Explore the full management transaction log of 迪哲医药, a listed issuer based in France. Shares are quoted on FR FR, under the supervision of AMF. Market capitalisation: €26.6bn. The latest transaction was reported on 21 August 2025 — Purchase. Among the most active insiders: XIAOLIN ZHANG. All data is free.
18
Insider Decl.
0
Thresholds
€1,972
3 ops.
Buy Volume
€13m
15 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
50.82 €
Income statement
Revenue801.1 M€
Gross profit766.9 M€96% margin
Net income−764.0 M€-95.4% margin
Balance sheet & cash
Market cap26.56 Bn€
Total debt1.24 Bn€
Free Cash Flow−758.8 M€
Last declaration on 21 August 2025
Declarations18 total
Executives●Purchase11SSE
€1,972200 shares
A股XSHG
SSE:173000009384407520·
Ideal exit: 18 May 2026 (T+270)
Executives●Sale11SSE
€20,7592,500 shares
A股XSHG
SSE:173000009275968160·
Executives●Sale11SSE
€620,55675,000 shares
A股XSHG
SSE:173000009275962660·
Executives●Sale11SSE
€32,2634,000 shares
A股XSHG
SSE:173000009272439100·
Executives●Sale11SSE
€28,5013,500 shares
A股XSHG
SSE:173000009263140640·
Executives●Sale21SSE
€914,480150,257 shares
A股XSHG
SSE:173000008803439580·
Executives●Sale21SSE
€926,158151,563 shares
A股XSHG
SSE:173000008794927600·
Executives●Purchase7SSE
160,972 shares
A股XSHG
SSE:173000007328115200·
Ideal exit: 4 Nov 2024 (T+270)
Executives●Purchase7SSE
3,550,000 shares
A股XSHG
SSE:173000007307413570·
Ideal exit: 1 Nov 2024 (T+270)
18 of 18 declarations